Collegium Pharmaceutical (COLL) Cash & Equivalents Growth (3y) (2017 - 2026)
Collegium Pharmaceutical (COLL) Cash & Equivalents Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 21.81% |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 11.05% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -4.92% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 7.80% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 19.10% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 12.11% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 27.55% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 13.03% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 32.82% |
| 10 | Collegium Pharmaceutical | 887.15 Mn | 737.84 Mn | 110.29 Mn | -23.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23.01% |
| Mar 31, 2026 | -0.10% |
| Dec 31, 2025 | 10.01% |
| Sep 30, 2025 | 3.82% |
| Jun 30, 2025 | -1.48% |
| Mar 31, 2025 | -3.40% |
| Dec 31, 2024 | -27.66% |
| Sep 30, 2024 | -41.36% |
| Jun 30, 2024 | -5.17% |
| Mar 31, 2024 | 7.74% |
| Dec 31, 2023 | 11.13% |
| Sep 30, 2023 | 16.05% |
| Jun 30, 2023 | 24.89% |
| Mar 31, 2023 | 32.37% |
| Dec 31, 2022 | 0.71% |
| Sep 30, 2022 | -4.47% |
| Jun 30, 2022 | -6.20% |
| Mar 31, 2022 | -7.52% |
| Dec 31, 2021 | 8.33% |
| Sep 30, 2021 | 11.40% |